Application of the Eighth AJCC TNM Staging System in Patients With Esophageal Squamous Cell Carcinoma

2018/04/05 by Po-Kuei Hsu, Po‐Kuei Hsu, Hui‐Shan Chen +4 · 15 citations
Medicine · #Esophageal Cancer Research and Treatment #Pancreatic and Hepatic Oncology Research #Colorectal and Anal Carcinomas

paper · doi:10.1016/j.athoracsur.2017.12.032

Cited by

• Strong expression of Id-1 in metastatic lymph nodes from esophageal squamous cell carcinoma is associated with better clinical outcome. [europepmc]
• Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study. [europepmc]
• Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal Cancer. [europepmc]
• Late-onset anastomotic leak following sweet esophagectomy: A case report and review of the literature. [europepmc]
• Exosome-Encapsulated MicroRNA-21 from Esophageal Squamous Cell Carcinoma Cells Enhances Angiogenesis of Human Umbilical Venous Endothelial Cells by Targeting SPRY1. [europepmc]
• Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus. [europepmc]
• A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging. [europepmc]
• Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma. [europepmc]
• Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy. [europepmc]
• Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma. [europepmc]
• A approach of gastric conduit via the anterior of pulmonary hilum route during minimally invasive McKeown esophagectomy. [europepmc]
• Preoperative immune prognostic index predicts the prognosis and postoperative adjuvant chemotherapy benefits of esophageal squamous cell carcinoma after minimally invasive esophagectomy. [europepmc]
• Development and validation of a prognostic model for overall survival in pN0 esophageal cancer patients after neoadjuvant chemotherapy: a SEER database-based study. [europepmc]
• Real-world applications of postneoadjuvant stage I of the staging system for oesophageal squamous cell cancer: what is beyond a pathological complete response? [europepmc]
• Development and validation of a nomogram for predicting long-term survival in pN + esophageal squamous cell carcinoma treated using radical resection without neoadjuvant therapy. [europepmc]